HealthStream (NASDAQ:HSTM) Stock Rating Upgraded by Wall Street Zen

HealthStream (NASDAQ:HSTM) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Sunday, Wall Street Zen reports.

Several other research firms have also commented on HSTM. Weiss Ratings raised HealthStream from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 23rd. Canaccord Genuity Group lifted their target price on shares of HealthStream from $24.00 to $27.00 and gave the company a “hold” rating in a report on Tuesday, July 21st. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat, HealthStream currently has a consensus rating of “Hold” and a consensus target price of $27.00.

HealthStream Price Performance

Shares of HSTM opened at $29.05 on Friday. HealthStream has a 1-year low of $19.50 and a 1-year high of $31.11. The stock has a market cap of $848.84 million, a PE ratio of 40.35, a price-to-earnings-growth ratio of 3.40 and a beta of 0.44. The firm has a fifty day moving average price of $28.21 and a 200 day moving average price of $24.41.

HealthStream (NASDAQ:HSTM) last posted its earnings results on Monday, August 3rd. The technology company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.06. The business had revenue of $83.73 million for the quarter, compared to analysts’ expectations of $80.82 million. HealthStream had a return on equity of 6.81% and a net margin of 6.60%. As a group, equities analysts expect that HealthStream will post 0.72 EPS for the current fiscal year.

Insider Activity at HealthStream

In other news, Director Linda Rebrovick sold 6,000 shares of the firm’s stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $29.00, for a total transaction of $174,000.00. Following the completion of the transaction, the director directly owned 51,329 shares of the company’s stock, valued at $1,488,541. This trade represents a 10.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 20.40% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On HealthStream

Several hedge funds have recently bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB lifted its position in shares of HealthStream by 76.4% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,025 shares of the technology company’s stock valued at $28,000 after acquiring an additional 444 shares in the last quarter. Danske Bank A S increased its position in HealthStream by 175.0% during the 4th quarter. Danske Bank A S now owns 1,100 shares of the technology company’s stock worth $25,000 after purchasing an additional 700 shares in the last quarter. Global Retirement Partners LLC acquired a new position in HealthStream in the 2nd quarter valued at about $31,000. Essential Partners LLC acquired a new position in HealthStream in the 1st quarter valued at about $25,000. Finally, Hantz Financial Services Inc. boosted its stake in shares of HealthStream by 2,035.5% during the 4th quarter. Hantz Financial Services Inc. now owns 1,324 shares of the technology company’s stock worth $31,000 after purchasing an additional 1,262 shares during the last quarter. Hedge funds and other institutional investors own 69.58% of the company’s stock.

HealthStream Company Profile

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.